nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—RNASE3—blood plasma—bipolar disorder	0.102	0.359	CbGeAlD
Pranlukast—MUC2—nervous system—bipolar disorder	0.0212	0.0745	CbGeAlD
Pranlukast—CYP2C9—urine—bipolar disorder	0.0204	0.0716	CbGeAlD
Pranlukast—MUC2—cerebellum—bipolar disorder	0.0199	0.0701	CbGeAlD
Pranlukast—MUC2—brain—bipolar disorder	0.0162	0.057	CbGeAlD
Pranlukast—CYP3A4—urine—bipolar disorder	0.0155	0.0546	CbGeAlD
Pranlukast—NFKB1—thyroid gland—bipolar disorder	0.0144	0.0505	CbGeAlD
Pranlukast—NFKB1—nervous system—bipolar disorder	0.0121	0.0425	CbGeAlD
Pranlukast—CYSLTR1—nervous system—bipolar disorder	0.0119	0.0417	CbGeAlD
Pranlukast—NFKB1—cerebellum—bipolar disorder	0.0114	0.04	CbGeAlD
Pranlukast—CYP2C9—blood plasma—bipolar disorder	0.0106	0.0374	CbGeAlD
Pranlukast—NFKB1—brain—bipolar disorder	0.00923	0.0325	CbGeAlD
Pranlukast—CYSLTR1—brain—bipolar disorder	0.00907	0.0319	CbGeAlD
Pranlukast—CYP3A4—blood plasma—bipolar disorder	0.0081	0.0285	CbGeAlD
Pranlukast—CYP3A4—nervous system—bipolar disorder	0.00241	0.00847	CbGeAlD
Pranlukast—TNF—Developmental Biology—ANK3—bipolar disorder	0.000842	0.00118	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—ADCY2—bipolar disorder	0.00084	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TRPC3—bipolar disorder	0.000837	0.00117	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—DRD3—bipolar disorder	0.000835	0.00117	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TRPC3—bipolar disorder	0.000833	0.00116	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—DRD2—bipolar disorder	0.000832	0.00116	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—GSK3B—bipolar disorder	0.000824	0.00115	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—BDNF—bipolar disorder	0.000816	0.00114	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—DRD4—bipolar disorder	0.000811	0.00113	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—NTRK1—bipolar disorder	0.000804	0.00112	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL1B—bipolar disorder	0.000799	0.00112	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—NRG1—bipolar disorder	0.000798	0.00111	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—ADM—bipolar disorder	0.000794	0.00111	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CACNB2—bipolar disorder	0.000779	0.00109	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.000776	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PDE4B—bipolar disorder	0.000774	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TSHB—bipolar disorder	0.000774	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TACR1—bipolar disorder	0.000774	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AKR1C4—bipolar disorder	0.000771	0.00108	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—NR3C1—bipolar disorder	0.000765	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NTRK1—bipolar disorder	0.000764	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL1B—bipolar disorder	0.000764	0.00107	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—ADCY2—bipolar disorder	0.000763	0.00107	CbGpPWpGaD
Pranlukast—IL5—Immune System—GSK3A—bipolar disorder	0.00076	0.00106	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—DRD2—bipolar disorder	0.000755	0.00106	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—IL1B—bipolar disorder	0.000747	0.00104	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—IL1B—bipolar disorder	0.000747	0.00104	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—HTR2A—bipolar disorder	0.00074	0.00103	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—BDNF—bipolar disorder	0.000736	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—GSK3B—bipolar disorder	0.000732	0.00102	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—HTR2A—bipolar disorder	0.000732	0.00102	CbGpPWpGaD
Pranlukast—IL5—Immune System—HLA-E—bipolar disorder	0.000729	0.00102	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CACNA1C—bipolar disorder	0.000712	0.000995	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DGKH—bipolar disorder	0.00071	0.000992	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR1A—bipolar disorder	0.000706	0.000986	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—GSK3B—bipolar disorder	0.000699	0.000976	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—MB21D1—bipolar disorder	0.000697	0.000974	CbGpPWpGaD
Pranlukast—IL5—Immune System—ADCY2—bipolar disorder	0.000697	0.000974	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—TAC1—bipolar disorder	0.000695	0.000971	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TRPC3—bipolar disorder	0.000685	0.000958	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL1B—bipolar disorder	0.000685	0.000958	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—DRD1—bipolar disorder	0.000681	0.000952	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2C—bipolar disorder	0.000681	0.000952	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—INS—bipolar disorder	0.000672	0.000939	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC5A3—bipolar disorder	0.000667	0.000932	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—DRD3—bipolar disorder	0.00066	0.000922	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—NRG1—bipolar disorder	0.000656	0.000916	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADM—bipolar disorder	0.000654	0.000914	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—GRIN1—bipolar disorder	0.000651	0.00091	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD5—bipolar disorder	0.000649	0.000907	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—GSK3B—bipolar disorder	0.000647	0.000904	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR1A—bipolar disorder	0.000641	0.000895	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—DRD4—bipolar disorder	0.000641	0.000895	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.00064	0.000894	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TRPC3—bipolar disorder	0.000638	0.000892	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PDE4B—bipolar disorder	0.000637	0.00089	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TACR1—bipolar disorder	0.000637	0.00089	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TSHB—bipolar disorder	0.000637	0.00089	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RGS4—bipolar disorder	0.000637	0.000889	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—TAC1—bipolar disorder	0.000631	0.000882	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL1B—bipolar disorder	0.000624	0.000872	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—AKR1C4—bipolar disorder	0.00062	0.000866	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—DRD1—bipolar disorder	0.000619	0.000865	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2C—bipolar disorder	0.000619	0.000865	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL1B—bipolar disorder	0.000609	0.000851	CbGpPWpGaD
Pranlukast—IL5—Immune System—S100B—bipolar disorder	0.000607	0.000849	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000603	0.000843	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—DRD3—bipolar disorder	0.000599	0.000838	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—DRD2—bipolar disorder	0.000597	0.000834	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CACNB2—bipolar disorder	0.000593	0.000829	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—POMC—bipolar disorder	0.000591	0.000826	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—HTR2A—bipolar disorder	0.000583	0.000814	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—DRD4—bipolar disorder	0.000582	0.000813	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL1B—bipolar disorder	0.000572	0.000799	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000569	0.000795	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—GRIN2B—bipolar disorder	0.000563	0.000787	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—ADCY2—bipolar disorder	0.000548	0.000765	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CACNA1C—bipolar disorder	0.000543	0.000758	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—DRD2—bipolar disorder	0.000542	0.000757	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL1B—bipolar disorder	0.000542	0.000757	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—IL1B—bipolar disorder	0.000536	0.000749	CbGpPWpGaD
Pranlukast—IL5—Immune System—NRG1—bipolar disorder	0.000536	0.000749	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—GSK3A—bipolar disorder	0.00053	0.000741	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR2A—bipolar disorder	0.000529	0.000739	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR1A—bipolar disorder	0.000527	0.000737	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TAC1—bipolar disorder	0.000519	0.000726	CbGpPWpGaD
Pranlukast—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000514	0.000718	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2C—bipolar disorder	0.000509	0.000712	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—DRD1—bipolar disorder	0.000509	0.000712	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—GSK3A—bipolar disorder	0.000509	0.000711	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—HLA-E—bipolar disorder	0.000509	0.000711	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—GSK3B—bipolar disorder	0.000507	0.000709	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—TRPC3—bipolar disorder	0.000505	0.000706	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NTRK2—bipolar disorder	0.000496	0.000692	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—DRD3—bipolar disorder	0.000493	0.000689	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TRPC3—bipolar disorder	0.000492	0.000687	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GSK3A—bipolar disorder	0.000491	0.000686	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—HLA-E—bipolar disorder	0.000488	0.000682	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ADCY2—bipolar disorder	0.000486	0.00068	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—DRD4—bipolar disorder	0.000479	0.000669	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—GSK3B—bipolar disorder	0.000476	0.000665	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL1B—bipolar disorder	0.000475	0.000664	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADM—bipolar disorder	0.000469	0.000656	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—POMC—bipolar disorder	0.000465	0.00065	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TSHB—bipolar disorder	0.000457	0.000639	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PDE4B—bipolar disorder	0.000457	0.000639	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TACR1—bipolar disorder	0.000457	0.000639	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADCY2—bipolar disorder	0.000451	0.00063	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TCF7L2—bipolar disorder	0.000449	0.000628	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—DRD2—bipolar disorder	0.000446	0.000623	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AKR1C4—bipolar disorder	0.000437	0.00061	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1B—bipolar disorder	0.000434	0.000606	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—GRIN2B—bipolar disorder	0.000429	0.000599	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—S100B—bipolar disorder	0.000424	0.000592	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—POMC—bipolar disorder	0.000422	0.00059	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—bipolar disorder	0.000422	0.00059	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000418	0.000584	CbGpPWpGaD
Pranlukast—CYP2C9—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000417	0.000582	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1B—bipolar disorder	0.000409	0.000571	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NTRK1—bipolar disorder	0.000404	0.000564	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DGKH—bipolar disorder	0.000402	0.000561	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—S100B—bipolar disorder	0.000393	0.000549	CbGpPWpGaD
Pranlukast—IL5—Immune System—GSK3B—bipolar disorder	0.000389	0.000544	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2A—bipolar disorder	0.00038	0.00053	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR1A—bipolar disorder	0.000379	0.000529	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—NRG1—bipolar disorder	0.000374	0.000523	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TAC1—bipolar disorder	0.000373	0.000521	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD5—bipolar disorder	0.000368	0.000514	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C4—bipolar disorder	0.000366	0.000511	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2C—bipolar disorder	0.000366	0.000511	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD1—bipolar disorder	0.000366	0.000511	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RGS4—bipolar disorder	0.00036	0.000504	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—NRG1—bipolar disorder	0.000359	0.000502	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—bipolar disorder	0.000356	0.000498	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NTRK2—bipolar disorder	0.000356	0.000497	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD3—bipolar disorder	0.000354	0.000495	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GSK3A—bipolar disorder	0.000353	0.000493	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NRG1—bipolar disorder	0.000347	0.000484	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD4—bipolar disorder	0.000344	0.00048	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—COMT—bipolar disorder	0.000342	0.000478	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—MAOA—bipolar disorder	0.00034	0.000475	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—bipolar disorder	0.000339	0.000474	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—COMT—bipolar disorder	0.000338	0.000472	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	0.000335	0.000468	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—POMC—bipolar disorder	0.000334	0.000467	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ADCY2—bipolar disorder	0.000332	0.000464	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—NR1D1—bipolar disorder	0.000329	0.000459	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADCY2—bipolar disorder	0.000324	0.000452	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TCF7L2—bipolar disorder	0.000322	0.000451	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—DRD2—bipolar disorder	0.00032	0.000447	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2A—bipolar disorder	0.000312	0.000437	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—GSK3A—bipolar disorder	0.000309	0.000431	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—GSK3B—bipolar disorder	0.000307	0.00043	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—INS—bipolar disorder	0.000303	0.000424	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—POMC—bipolar disorder	0.000303	0.000424	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—HLA-E—bipolar disorder	0.000296	0.000414	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—IMPA2—bipolar disorder	0.000293	0.000409	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NTRK1—bipolar disorder	0.00029	0.000405	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—bipolar disorder	0.000286	0.0004	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ADCY2—bipolar disorder	0.000283	0.000396	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—S100B—bipolar disorder	0.000282	0.000394	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TRPC3—bipolar disorder	0.000279	0.000389	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—bipolar disorder	0.000275	0.000384	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—GSK3B—bipolar disorder	0.000271	0.000379	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADM—bipolar disorder	0.000266	0.000371	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—GSK3B—bipolar disorder	0.000261	0.000364	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TACR1—bipolar disorder	0.000259	0.000362	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDE4B—bipolar disorder	0.000259	0.000362	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TSHB—bipolar disorder	0.000259	0.000362	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GSK3B—bipolar disorder	0.000252	0.000352	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—POMC—bipolar disorder	0.00025	0.000349	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NRG1—bipolar disorder	0.000249	0.000348	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—INS—bipolar disorder	0.000248	0.000347	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—S100B—bipolar disorder	0.000247	0.000345	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—GSK3B—bipolar disorder	0.000234	0.000327	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—INS—bipolar disorder	0.000231	0.000323	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—COMT—bipolar disorder	0.000226	0.000315	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2A—bipolar disorder	0.000224	0.000313	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—MAOA—bipolar disorder	0.000224	0.000313	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—COMT—bipolar disorder	0.000223	0.000311	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CLOCK—bipolar disorder	0.000223	0.000311	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—POMC—bipolar disorder	0.000221	0.000309	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—NRG1—bipolar disorder	0.000218	0.000304	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR1A—bipolar disorder	0.000214	0.000299	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TAC1—bipolar disorder	0.000211	0.000295	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2C—bipolar disorder	0.000207	0.000289	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD1—bipolar disorder	0.000207	0.000289	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NTRK2—bipolar disorder	0.000201	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD3—bipolar disorder	0.0002	0.00028	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GSK3A—bipolar disorder	0.0002	0.000279	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—IMPA1—bipolar disorder	0.000198	0.000276	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD4—bipolar disorder	0.000195	0.000272	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—bipolar disorder	0.000193	0.00027	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—IMPA2—bipolar disorder	0.000193	0.00027	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADCY2—bipolar disorder	0.000183	0.000256	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TCF7L2—bipolar disorder	0.000183	0.000255	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—DRD2—bipolar disorder	0.000181	0.000253	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GSK3B—bipolar disorder	0.000181	0.000252	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—POMC—bipolar disorder	0.000179	0.00025	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—INS—bipolar disorder	0.000178	0.000249	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NDUFV2—bipolar disorder	0.000168	0.000235	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NTRK1—bipolar disorder	0.000164	0.000229	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AKR1C4—bipolar disorder	0.000163	0.000228	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—S100B—bipolar disorder	0.00016	0.000223	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—GSK3B—bipolar disorder	0.000158	0.000221	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NR1D1—bipolar disorder	0.000146	0.000205	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—POMC—bipolar disorder	0.000146	0.000204	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NRG1—bipolar disorder	0.000141	0.000197	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NCAN—bipolar disorder	0.00014	0.000196	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SLC5A3—bipolar disorder	0.000137	0.000192	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—IMPA1—bipolar disorder	0.00013	0.000182	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—bipolar disorder	0.000127	0.000177	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—bipolar disorder	0.000116	0.000163	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NDUFV2—bipolar disorder	0.000111	0.000155	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AKR1C4—bipolar disorder	0.000107	0.00015	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GSK3B—bipolar disorder	0.000102	0.000143	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—POMC—bipolar disorder	0.000101	0.000142	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—INS—bipolar disorder	0.000101	0.000141	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CLOCK—bipolar disorder	9.92e-05	0.000139	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TSHB—bipolar disorder	9.66e-05	0.000135	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPH2—bipolar disorder	9.66e-05	0.000135	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CACNB2—bipolar disorder	9.66e-05	0.000135	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NR1D1—bipolar disorder	9.65e-05	0.000135	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DPYD—bipolar disorder	9.51e-05	0.000133	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NCAN—bipolar disorder	9.23e-05	0.000129	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SLC5A3—bipolar disorder	9.04e-05	0.000126	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CACNA1C—bipolar disorder	8.84e-05	0.000123	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PIK3C2A—bipolar disorder	8.61e-05	0.00012	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—bipolar disorder	8.5e-05	0.000119	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SNAP25—bipolar disorder	7.72e-05	0.000108	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ADCY2—bipolar disorder	6.84e-05	9.55e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CLOCK—bipolar disorder	6.54e-05	9.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TSHB—bipolar disorder	6.37e-05	8.9e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CACNB2—bipolar disorder	6.37e-05	8.9e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPH2—bipolar disorder	6.37e-05	8.9e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DPYD—bipolar disorder	6.27e-05	8.76e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—COMT—bipolar disorder	5.85e-05	8.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CACNA1C—bipolar disorder	5.83e-05	8.14e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MAOA—bipolar disorder	5.81e-05	8.12e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	5.68e-05	7.94e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SNAP25—bipolar disorder	5.09e-05	7.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—MTHFR—bipolar disorder	4.73e-05	6.61e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ADCY2—bipolar disorder	4.51e-05	6.3e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—COMT—bipolar disorder	3.86e-05	5.39e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MAOA—bipolar disorder	3.83e-05	5.36e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—POMC—bipolar disorder	3.78e-05	5.29e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—INS—bipolar disorder	3.76e-05	5.26e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—MTHFR—bipolar disorder	3.12e-05	4.36e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—POMC—bipolar disorder	2.5e-05	3.49e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—INS—bipolar disorder	2.48e-05	3.47e-05	CbGpPWpGaD
